RETACRIT 20000 [iU]/mL (Epoetin Alfa-Epbx INJECTION, SOLUTION) 20000 [iU]/mL

RETACRIT 20000 [iU]/mL is an injectable solution containing epoetin alfa-epbx, used to support red blood cell production. This multi-dose vial is suitable for intravenous or subcutaneous administration.

Strength

20000 [iU]/mL

Pack Size

10 VIAL, MULTI-DOSE in 1 CARTON (0069-1311-10) / 1 mL in 1 VIAL, MULTI-DOSE (0069-1311-01)

Manufacturer / TM Owner

Pfizer Laboratories Div Pfizer Inc

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

RETACRIT 20000 [iU]/mL is primarily used to manage anemia in patients with chronic kidney disease or those undergoing chemotherapy. It works by stimulating the bone marrow to produce more red blood cells, which can help improve oxygen levels in the body. People often ask, 'What is RETACRIT used for?' and the answer is that it is commonly prescribed for conditions that cause low red blood cell counts.

Side Effects

Common effects of RETACRIT 20000 [iU]/mL may include injection site reactions, such as redness or swelling. Some users might experience flu-like symptoms, including fever, chills, or muscle aches. These effects are generally mild and temporary, but if they persist or worsen, it is important to consult a healthcare provider.

Precautions & Warnings

RETACRIT 20000 [iU]/mL should be handled with care to avoid contamination. It is important to use a sterile needle and syringe for each injection. The solution should be stored at the recommended temperature to maintain its effectiveness. Always follow the instructions provided by your healthcare provider for safe administration.

Avoid Interactions

RETACRIT 20000 [iU]/mL may interact with certain medications, including those that affect blood pressure or immune system function. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should also be discussed with your healthcare provider, as it may affect the effectiveness of the treatment.

Frequently Asked Questions

RETACRIT 20000 [iU]/mL is used to manage anemia in patients with chronic kidney disease or those undergoing chemotherapy.

RETACRIT 20000 [iU]/mL can be administered either intravenously or subcutaneously, following the instructions provided by your healthcare provider.

Common side effects may include injection site reactions, flu-like symptoms, and mild discomfort.

RETACRIT 20000 [iU]/mL should be stored at the recommended temperature to maintain its effectiveness.

RETACRIT 20000 [iU]/mL may interact with medications that affect blood pressure or immune system function.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.